» Articles » PMID: 22386834

A Study of the 3-year Incidence of Diabetic Retinopathy in a French Diabetic Population Seen at Lariboisière Hospital, Paris

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2012 Mar 6
PMID 22386834
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study evaluated the incidence of diabetic retinopathy (DR) over a 3-year period in a French population that was followed by OPHDIAT®, and assessed the clinical and biological risk factors associated with incident retinopathy.

Methods: The studied patients were screened for DR during hospitalization for their annual diabetes check-up in the endocrinology department by two examinations three years apart. DR screening used the OPHDIAT® telemedical network, and the examination included clinical and biological data.

Results: A total of 254 patients were studied. At the 3-year follow-up, the incidence was 14.0%, (CI: 9.5-18.4%). Longer duration of diabetes and the presence of micro- or macroalbuminuria were significantly associated with incident retinopathy (P<0.05). Other potential risk factors were not statistically significantly related to DR progression, and only treatment with insulin showed a trend towards significance (P<0.20).

Conclusion: This study provides the first French data on the incidence of DR, which was estimated after a 3-year follow-up at 14.0%. Longer duration of time from the onset of diabetes and higher baseline albuminuria were the only statistically significant risk factors found for the incidence of DR after our 3-year study. Nevertheless, microalbuminuria should be more widely used in ophthalmological practice in the assessment of DR, as is already the case for both blood pressure and HbA(1c).

Citing Articles

Analysis of independent risk factors for progression of different degrees of diabetic retinopathy as well as non-diabetic retinopathy among type 2 diabetic patients.

Li Z, Tong J, Liu C, Zhu M, Tan J, Kuang G Front Neurosci. 2023; 17:1143476.

PMID: 37090790 PMC: 10115960. DOI: 10.3389/fnins.2023.1143476.


Five-Year Incidence and Progression of Diabetic Retinopathy in Patients with Type II Diabetes in a Tertiary Care Center in Lebanon.

Mehanna C, Abdul Fattah M, Tamim H, Nasrallah M, Zreik R, Haddad S J Ophthalmol. 2018; 2017:9805145.

PMID: 30116622 PMC: 6079417. DOI: 10.1155/2017/9805145.


Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Lee R, Wong T, Sabanayagam C Eye Vis (Lond). 2015; 2:17.

PMID: 26605370 PMC: 4657234. DOI: 10.1186/s40662-015-0026-2.


The empirical evidence for the telemedicine intervention in diabetes management.

Bashshur R, Shannon G, Smith B, Woodward M Telemed J E Health. 2015; 21(5):321-54.

PMID: 25806910 PMC: 4432488. DOI: 10.1089/tmj.2015.0029.


The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients.

Jin P, Peng J, Zou H, Wang W, Fu J, Shen B PLoS One. 2014; 9(11):e113359.

PMID: 25402474 PMC: 4234658. DOI: 10.1371/journal.pone.0113359.